Urologists Practice Spotting Tumors With Virtual Reality Technology
BOSTON (CBS) – Virtual reality is being used in healthcare more, and a local company is using the technology to help doctors identify hard-to-see tumors in the bladder.
Almost 80,000 Americans are diagnosed with bladder cancer every year. To find bladder tumors, a urologist looks directly at the inside of the bladder using a cystoscope, a small tube with a camera and light attached.
Cystoscopes are equipped with technology called narrow band imaging. (WBZ-TV)
Some tumors are harder to find. But to make it easier, many cystoscopes are equipped with technology called narrow band imaging (NBI).
“What NBI does is it change...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 29, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall HealthWatch Local TV Virtual Reality Source Type: news
Karl Storz Focuses on Bladder Cancer Detection With New Device
Karl Storz is focusing on bladder cancer detection with its latest product. The El Segunda, CA-based company said it is launching the PDD Blue Light Flexible Video Cytoscopy System. The product launch follows the approval of a supplemental new drug application and a premarket approval supplement from FDA extending the indication for Blue Light Cystoscopy with Cysview (BLCC) to include use of the new Karl Storz PDD Blue Light Flexible Video Cystoscope.
Also included in the approval is an expanded indication for the repetitive use of Cysview within the same patient and for the identification of Carcinoma in Situ (CIS); one o...
Source: MDDI - May 18, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Photocure Announces Blue Light Cystoscopy with Cysview(R) Now Available for Surveillance of Bladder Cancer
OSLO, Norway, May 16, 2018 -- (Healthcare Sales & Marketing Network) -- Photocure ASA (OSE: PHO), May 16, 2018, announced today the launch of Blue Light Cystoscopy (BLC) with Cysview for a new indication of surveillance cystoscopy of bladder cancer.
... Devices, Diagnostics, Oncology, Product Launch Photocure, Karl Storz, Blue Light Cystoscopy, Cysview, bladder cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news
Laborie Medical closes $214m Cogentix buy
Laborie Medical Technologies said today that it closed the $214 million acquisition of Cogentix Medical (NSDQ:CGNT).
With about 85% of the urology and gynecology device maker’s shares tendered over the weekend, meeting the minimum tender requirement, the stage was set for the deal to close today. The $3.85-per-share cash tender pulled in some 51.5 million shares, for about $198.2 million, Laborie said April 21.
The deal represents a 14.2% premium over CGNT stock’s $3.37 closing price March 9, the last business day before the deal was announced.
“Our combined, complementary product portfolio provides our...
Source: Mass Device - April 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Urology Women's Health Cogentix Medical Laborie Medical Technologies Source Type: news
UroViu wins FDA nod for disposable diagnostic cytoscope
UroViu said yesterday it won FDA 510(k) clearance for its Uro-V single-use diagnostic cytoscopic system designed to visually assess the urethra and urinary bladder in instances of suspected pathology or dysfunction.
The Bellevue, Wash.-based company’s newly cleared Uro-V device is a self-contained single-use diagnostic cytoscope designed for female diagnostic cytoscopy. The system is designed to be light-weight, portable and battery powered with a disposable cannula and a reusable handle, video processor, LCD display and touchscreen display.
“Today’s growing and aging population faces a severe problem of ...
Source: Mass Device - March 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Diagnostics Food & Drug Administration (FDA) Regulatory/Compliance Urology uroviu Source Type: news
Response and Development of Immune-Related Adverse Events in an 83-Year-Old Man With Metastatic Urothelial Cancer
An 83-year-old man was diagnosed with multiple low-grade transitional cell carcinomas over a 6-year period. A surveillance cystoscopy in year 7 showed high-grade noninvasive papillary urothelial carcinoma in the bladder trigone. A CT urogram showed a soft-tissue mass with diffuse enhancement in the lower pole of the left kidney, concerning for malignancy. (Source: CancerNetwork)
Source: CancerNetwork - March 15, 2018 Category: Cancer & Oncology Authors: Daniel P. Petrylak, MD Karishma K. Mehra, MD Tags: Bladder Cancer Genitourinary Cancers Oncology Journal Source Type: news
Laborie Set to Acquire Cogentix
Laborie Medical Technologies is set to acquire Cogentix Medical for about $239 million in a deal that will close in the second quarter of 2018. The price represents a 28% premium over Cogentix average 30-day closing price.
Minnetonka, MN-based Cogentix specializes in urology devices. The firm’s products include Urgent PC, a neuromodulation system for percutaneous tibial nerve stimulation. It treats overactive bladder and associated symptoms of urinary urgency, urinary frequency, and urge incontinence on an outpatient basis.
Join us at the BIOMEDevice Boston Expo, April 18–19, 2018. Use promo code "MDDI" for 20% off c...
Source: MDDI - March 13, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Laborie Medical to pay $214m for Cogentix
Laborie Medical Technologies said today that it agreed to pay $214 million for Cogentix Medical (NSDQ:CGNT) and its line of urology and gynecology devices.
Formed by the 2015 merger of Vision-Sciences and Uroplasty, Minnetonka, Minn.-based Cogentix makes the Urgent PC neuromodulation device for treating overactive bladder syndrome, the PrsimeSight cystoscopy and EndoSheath devices and Macroplastique, an injectable soft-tissue bulking agent for treating female stress urinary incontinence.
The $3.85-per share cash offer is slated to close during the first half of the year, Toronto-based Laborie said. It’s a 14.2...
Source: Mass Device - March 12, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Urology Wall Street Beat Women's Health Cogentix Medical Laborie Medical Technologies Source Type: news
Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview(R)
OSLO, Norway, Feb. 16, 2018 -- (Healthcare Sales & Marketing Network) -- Photocure ASA (OSE: PHO), announced today that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the indication for Blue Lig... Devices, Oncology, FDA Photocure, KARL STORZ, Blue Light Cystoscopy, Cysview, bladder cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 16, 2018 Category: Pharmaceuticals Source Type: news
Cystoscopy
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - January 13, 2018 Category: Consumer Health News Source Type: news
Urine test UroMark could save NHS millions
Developed by researchers at University College London, UroMark can detect bladder cancer in 98 per cent of cases, a figure equivalent to the results of cystoscopies. (Source: the Mail online | Health)
Source: the Mail online | Health - September 9, 2017 Category: Consumer Health News Source Type: news
Noninvasive Urine Test Predicts Bladder Cancer Recurrence Noninvasive Urine Test Predicts Bladder Cancer Recurrence
A new noninvasive test was more predictive of bladder cancer recurrence than standard cytology and cystoscopy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 21, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
What Causes Urinary Hesitancy?
Discussion
“Hesitancy” denotes difficulty in initiating voiding when the child is ready to void,” according to the International Children’s Continence Society. It is not seen that often in pediatrics in isolation, but is commonly associated with other symptoms such as dysuria, frequency, abdominal or anal pain which may indicate common problems such as a urinary tract infection, vaginal/perineal irritation, or constipation. Communication problems can also confound the accuracy of the history as patients and families can have a difficult time describing the urinary problem they are experiencing or ma...
Source: PediatricEducation.org - June 19, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Penile fracture following a fall in a seven year old male - Meenakshi-Sundaram B, Coco CT, Furr JR, Shaw MD, Frimberger DC.
We report a rare case of isolated penile fracture in a prepubescent male caused by an accidental fall. The patient presented with swelling and ecchymosis on the base of the penis and along the penile shaft. A flexible cystoscopy was performed which did not... (Source: SafetyLit)
Source: SafetyLit - May 19, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Ultrasound plus cystoscopy cost effective for diagnosis of AMH
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2017 Category: Drugs & Pharmacology Source Type: news
